Experimental drug may protect the heart in Duchenne muscular dystrophy

Researchers at the University of South Florida have identified that the experimental drug Setanaxib may protect cardiac function in patients with Duchenne muscular dystrophy. The study suggests that targeting the NOX4 enzyme could reduce heart enlargement and tissue scarring.